a 40 mg minocycline hydrochloride modified-release capsule for the treatment of rosacea. The FDA approved Emrosi in November 2024, ahead of the scheduled PDUFA date, and the company began initial ...

In a significant move to streamline and promote pharmaceutical exports, the Directorate General of Foreign Trade (DGFT) has issued Public Notice announcing the fixation of a new Standard Input Output ...

Right along the museum wall marked 1925, the year it all began, a crowd gathered Thursday to celebrate 100 years since construction ... The first: a time capsule dedication. Inside the capsule?

FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for Rosacea Emrosi Initial Distribution Ongoing; First Prescriptions Filled Total Revenues for the Full Year ...

1979) (see Table 1). A 100 mg dose taken twice daily of either minocycline or doxycycline is also effective. Full-strength dosing should last for 3–4 weeks or until a response is noted ...

A number of physical therapies are available for treating active acne, although their success is variable and some require considerable skill to perform. Glycolic acid and salicylic acid peels ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Topamax comes as a tablet or sprinkle capsule. It belongs to a group of drugs ... The typical starting dose of Topamax is 50 mg (25 mg twice per day). Your doctor may increase your dose by 50 ...